|
Venous Thromboembolism in the Critically Ill and Injured Preliminary Agenda: Thursday, September 4, 2008 |
|
8:00 a.m. – 8:15 a.m. Welcome and Overview Kenneth E. Wood, DO, FCCM |
|
8:15 a.m. – 8:45 a.m. Hematology for the Intensivist Timothy A. Morris, MD |
|
8:45 a.m. – 9:15 a.m. Epidemiology and Venous Thromboembolism Prevention William H. Geerts, MD |
|
9:15 a.m. – 9:45 a.m. Regulatory Requirements and Guidelines William H. Geerts, MD |
|
9:45 a.m. – 10:15 a.m. Break |
|
10:15 a.m. – 10:45 a.m. Implementation of Patient Safety Goals in the ICU Curtis E. Haas, PharmD |
|
10:45 a.m. – 11:15 a.m. Diagnostic Advances in Venous Thromboembolism Timothy A. Morris, MD |
|
11:15 a.m. – 11:45 a.m. Risk Stratification of Pulmonary Embolism in the Emergency Department and Intensive Care Unit Samuel Z. Goldhaber, MD |
|
11:45 a.m. – 12:15 p.m. Coagulation in Unique Populations in the ICU William E. Dager, PharmD |
|
12:15 p.m. – 1:15 p.m. Lunch on Your Own |
|
1:15 p.m. – 1:45 p.m. Controversies in Monitoring Antithrombotic Therapy Curtis E. Haas, PharmD |
|
1:45 p.m. – 2:15 p.m. Major Pulmonary Embolism Kenneth E. Wood, DO, FCCM |
|
2:15 p.m. – 2:45 p.m. Hemorrhagic Complications of Anticoagulation and Thrombolytic Therapy William E. Dager, PharmD |
|
2:45 p.m. – 3:15 p.m. Heparin-Induced Thrombocytopenia William E. Dager, PharmD |
|
3:15 p.m. – 3:30 p.m. Break |
|
3:30 p.m. – 4:00 p.m. New Anti-Coagulants Jack Ansell, MD |
|
4:00 p.m. – 4:30 p.m. Update on Inferior Vena Cava Filters William H. Geerts, MD |
|
4:30 p.m. – 5:00 p.m. Summary and Questions and Answers William E. Dager, PharmD; Kenneth E. Wood, DO, FCCM |
|
Friday, September 5, 2008 |
|
8:00 a.m. – 8:30 a.m. Catheter-Related and Upper Extremity Deep Vein Thrombosis Manish Tandon, MD |
|
8:30 a.m. – 9:00 a.m. Approach to Hypercoagulable States Jack Ansell, MD |
|
9:00 a.m. – 9:30 a.m. Controversies in Thrombosis Jeffrey Wiese, MD |
|
9:30 a.m. – 9:45 a.m. Break |
|
9:45 a.m. – 10:30 a.m. Debate: Thrombolytic Therapy for Hemodynamically Stable Patients with Right Ventricular Dysfunction Pro: Kenneth E. Wood, DO, FCCM Con: Timothy A. Morris, MD |
|
10:30 a.m. – 10:45 a.m. Debate: Questions and Answers Timothy A. Morris, MD; Kenneth E. Wood, DO, FCCM |
|
10:45 a.m. – 11:30 a.m. Debate: Prophylactic Use of Inferior Vena Cava Filters Pro: Kenneth E. Wood, DO, FCCM Con: Manish Tandon, MD |
|
11:30 a.m. – 11:45 a.m. Debate: Questions and Answers Manish Tandon, MD; Kenneth E. Wood, DO, FCCM |
|
11:45 a.m. – 12:00 p.m. Conference Summary William E. Dager, PharmD |